RSP Raises EUR 32 million with first tranche of Series C
A total of EUR 32.5 million has been raised by RSP Systems based on progress in developing and commercializing its non-invasive GlucoBeam™. The company is now in a Series C round of funding, which will support final technology development and preparation for their upcoming pivotal study anticipated in 2022. The current round is expected to […]
RSP Systems Joins The Soonicorn Club of Denmark
We are pleased to announce that RSP Systems A/S has been selected to be a part of the Soonicorn club of Denmark – an elite group of the most promising Denmark startups that have reached significant valuation milestones over the previous few years. RSP Systems was recognised as a Top Tech Minicorn in Denmark by […]
New CEO appointed
We are delighted to announce that the Board has appointed Anders Weber CEO of RSP Systems early this month. Anders brings business experience from the diagnostics industry, particularly blood glucose monitoring both from the established industry and the venture sector and he has been acting interim CEO of RSP Systems the past six months. All […]
World Diabetes Day 2019
November 14, 2019 marks the 28th World Diabetes day. This day was created in 1991 by the International Diabetes Federation and the World Health Organization in response to growing concerns of escalating health threat posed by diabetes. The number of people living with diabetes is estimated to rise from 415 million today to 642 million by […]
New RSP logo
We are excited to release the new visual identity of RSP Systems! We have taken our existing logo and updated it to better reflect our belief that technology can empower people’s lives by not being intrusive. The essence of our new logo: The shape is an oval to represent how RSP’s humanity and technology surround […]
ISO 13485 Audit demonstrates quality management strength
Remember to Celebrate – and enjoy the journey This week we were visited by an assessor who executed our first ISO1345:2016 surveillance audit. The purpose of an ISO 13485:2016 surveillance audit is to ensure that a company has procedures in place to ensure that we actually do what we say with respect to the development of a […]
Showcase of our trial-ready technology, GlucoBeam
We will exhibit our cutting-edge non-invasive glucose monitor, GlucoBeam at ATTD 2019 ATTD, one of the world’s leading scientific forums for showcasing the latest breakthroughs in diabetes technology, will be held in Berlin later this week. Set to make our first conference appearance as an exhibitor at the prestigious New Technologies Fair, we will unveil […]
RSP Systems closes Series B, bringing total funding to US$28 million
RSP Systems has completed its Series B at a total amount of US$15.5 million to accelerate regulatory approval and manufacturing of the GlucoBeam, a novel device that offers convenient and accurate noninvasive glucose monitoring for people with diabetes. RSP Systems A/S has received an additional US$3.3 million in financing from several key investors. The Series B closed at US$15.5 […]
Successful second closing of Series B round
RSP Systems adds US$4.6 million in a second closing of its Series B funding round, increasing the round total to US$12.3 million. Odense, Denmark, 10th September 2018 / B3C newswire / RSP Systems A/S, the non-invasive diagnostics company, announces that it has completed second closing of its Series B round. This closing brings in an […]
ISO 13485:2016 Certification awarded to RSP systems
It is with great pride that we announce our latest achievement! RSP Systems has been awarded the ISO 13485:2016 Certification from LRQA! For more information, click this link to the press release.
